Peptonic Medical buys 8.3% stake in DGH International for SEK 12.5 million

• Peptonic Medical bought 2,776,673 shares in DGH International, taking about 8.3% of votes and capital.
• Purchase price totaled SEK 12.5 million, funded by SEK 2.4 million cash, SEK 9 million seller loans, SEK 1.1 million deferred.
• Deferred payment due no later than Dec. 31, 2026.
• Sellers can request conversion of the SEK 9 million loan into Peptonic shares at 5-day VWAP, capped at SEK 0.001 per share.
• Board flagged risks tied to disputes and potential claims at DGH despite citing attractive risk-adjusted upside.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PEPTONIC Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20260902:BIT:5281:0) on September 02, 2026, and is solely responsible for the information contained therein.